Hui-Wen Cheng
- Co-authors
- Chung‐Ji LiuKuo‐Wei ChangShu‐Chun LinShou‐Yen KaoHsi‐Feng TuChien‐Huang LinBing-Chang ChenTung-Yiu Wong
- Topics
- Bioactive Compounds and Antitumor Agents (3 papers)MicroRNA in disease regulation (3 papers)Peptidase Inhibition and Analysis (3 papers)
- Cited by
- Cancer ResearchToxicologyImmunology
- Partner nations
- TaiwanIndiaUnited States
In The Last Decade
Hui-Wen Cheng
27 papers receiving 915 citations
Peers
Comparison fields: 5 of 119
- Molecular Biology 523
- Cancer Research 290
- Oncology 192
- Immunology 161
- Pulmonary and Respiratory Medicine 87
Countries citing papers authored by Hui-Wen Cheng
This map shows the geographic impact of Hui-Wen Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui-Wen Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui-Wen Cheng more than expected).
Fields of papers citing papers by Hui-Wen Cheng
This network shows the impact of papers produced by Hui-Wen Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui-Wen Cheng. The network helps show where Hui-Wen Cheng may publish in the future.
Co-authorship network of co-authors of Hui-Wen Cheng
This figure shows the co-authorship network connecting the top 25 collaborators of Hui-Wen Cheng. A scholar is included among the top collaborators of Hui-Wen Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui-Wen Cheng. Hui-Wen Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 12 | |
| 3 | 39 | |
| 4 | 6 | |
| 5 | 10 | |
| 6 | 31 | |
| 7 | 52 | |
| 8 | 64 | |
| 9 | 49 | |
| 10 | 18 | |
| 11 | 6 | |
| 12 | 52 | |
| 13 | 7 | |
| 14 | 37 | |
| 15 | 19 | |
| 16 | 127 | |
| 17 | 25 | |
| 18 | 47 | |
| 19 | 9 | |
| 20 | 6 |
About Hui-Wen Cheng
Hui-Wen Cheng is a scholar working on Toxicology, Cancer Research and Oncology, having authored 27 papers that have together received 929 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (3 papers), MicroRNA in disease regulation (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Cancer Research (290 citations), Toxicology (30 citations) and Immunology (161 citations). Hui-Wen Cheng has collaborated with scholars based in Taiwan, India and United States. Frequent co-authors include Chung‐Ji Liu, Kuo‐Wei Chang, Shu‐Chun Lin, Shou‐Yen Kao, Hsi‐Feng Tu, Chien‐Huang Lin, Bing-Chang Chen, Tung-Yiu Wong, Hsiao-Chin Hong and Szu‐Hua Pan. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.